Month: August 2022

– Three clinical data readouts across three programs expected in H2 2022 – – PKU Phase 3 readiness activities underway for planned start in H1 2023 – – $106.8 million in cash, cash equivalents and short-term investments support projected runway into 2024 – – Conference call and webcast at 8:30 a.m. ET today – CAMBRIDGE, Mass., Aug. 11, 2022 (GLOBE NEWSWIRE) — Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company developing medicines for metabolic and immunological diseases through its proprietary approach to synthetic biology, today reported financial results for the second quarter ended June 30, 2022 and provided an update on its pipeline programs. “We look forward to three clinical data readouts in the remainder of this year for our programs in phenylketonuria (PKU), homocystinuria (HCU) and enteric hyperoxaluria...

BROOKFIELD, NEWS, Aug. 11, 2022 (GLOBE NEWSWIRE) — Brookfield Reinsurance (NYSE, TSX: BAMR) today announced financial results for the quarter ended June 30, 2022. Sachin Shah, CEO of Brookfield Reinsurance, stated, “With the closing of American National, we now manage over $40 billion of assets, a substantial portion of which are in cash and short-dated liquid securities. Our focus now shifts to investing these assets for value in a rising rate environment.”UnauditedAs at and for the periods ended June 30(US$ millions, except per share amounts) Three Months Ended   Six Months Ended  2022     2021     2022     2021Total Assets $ 41,019   $ 2,640   $ 41,019   $ 2,640Adjusted equity1   3,767     1,252     3,767     1,252Distributable operating earnings1   46     3     59     6Net income2   1     2     129     5Net...

IDEX Biometrics ASA, a leading provider of advanced fingerprint authentication solutions for payment cards and adjacent applications, will give a webcast presentation today at 13:00 CET in connection with its interim report for the first half of 2022, focusing on the company’s business. The presentation will be held by Vince Graziani, Chief Executive Officer. The webcast presentation can be viewed at the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20220811_4/ The presentation file is attached to this notice (link below) and is also available on the IDEX Biometrics website: www.idexbiometrics.com/investors ContactsMarianne Bøe, Investor Relations E-mail: marianne.boe@idexbiometrics.comTel: + 47 9180 0186 Brett L. Perry, U.S. Investor RelationsE-mail: bperry@sheltongroup.comTel: +1 214 272 0070 About IDEX BiometricsIDEX...

— Second quarter 2022 UPNEEQ® net product sales of $8.4 million; 42% above first quarter — — Opportunity for cash runway to extend through 2023 following recently announced financings — — Expanded Board of Directors with the appointment of Alisa Lask, Aesthetic industry veteran with pharmaceutical experience in both sales and marketing — — Continued sequential expansion among key UPNEEQ demographics, including pharmacy-paid prescribers and medical aesthetics practices — BRIDGEWATER, N.J., Aug. 11, 2022 (GLOBE NEWSWIRE) — RVL Pharmaceuticals plc (Nasdaq: RVLP) (“RVL” or the “Company”), a specialty pharmaceutical company, today announced financial results and business highlights for the three months ended June 30, 2022. “Our recent financing and addition of Alisa Lask to our Board of...

Company to host webcast and conference call today at 8:30 a.m. ETMORRISVILLE, N.C., Aug. 11, 2022 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (“Liquidia” or the “Company”) today reported financial results for the second quarter ended June 30, 2022. The Company will host a webcast and conference call at 8:30 a.m. ET to discuss the second quarter 2022 financial results and provide a corporate update. Roger Jeffs, Liquidia’s Chief Executive Officer, said: “We continue to work towards the goal of launching YUTREPIA™ (treprostinil) inhalation powder as soon as possible upon resolution of the Hatch-Waxman litigation. It is encouraging to see the momentum and excitement building within the Company, between securing key wins on the legal front and bringing in new hires to help us achieve our near-term and long-term goals....

$5 Million of Non-Dilutive FinancingVeteran Biotech Executive Appointed to Board KANSAS CITY, Kan., Aug. 11, 2022 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a clinical-stage biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced its financial results for the quarter ended June 30, 2022, and provided a clinical and business update. Highlights include the announcement of $5 million of debt financing and the appointment of an additional member to Cingulate’s Board of Directors. “Cingulate continues to advance its mission in bringing next-generation medications to patients where standard-of-care treatments result in suboptimal outcomes. Millions of patients today who suffer...

–   1H 2022 Total Net Sales of $138.2 million, increasing 24.6% from 1H 2021–   1H 2022 Gross margin of 73.8%, up 294 bps from 1H 2021–   1H 2022 Pro Forma Adjusted EBITDA margin of 23.5% versus 22.8% in 1H 2021–   Q2 2022 Total Net Sales of $77.1 million, increasing 23.8% from Q2 2021–   Q2 2022 Gross margin of 75.1%, up 578 basis points from Q2 2021–   Q2 2022 Pro Forma Adjusted EBITDA margin of 28.4% versus 25.4% in Q2 2021–   Company Reaffirms Guidance NEW YORK, Aug. 11, 2022 (GLOBE NEWSWIRE) — Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, today announced results for the second quarter and first half of 2022. Michel Brousset, Waldencast Founder and CEO, said: “We are very pleased to report significant growth in net sales and Pro Forma...

Investable Cash and Capital Increases to over $110 billion $21 billion of Assets Sold Since Last Quarter, Realizing $5 billion of Gains BROOKFIELD, NEWS, Aug. 11, 2022 (GLOBE NEWSWIRE) — Brookfield (NYSE: BAM, TSX: BAM.A) today announced financial results for the quarter ended June 30, 2022. Nick Goodman, Chief Financial Officer of Brookfield, stated “We delivered strong results in the second quarter, supported by our resilient global portfolio of inflation protected real assets and record levels of fundraising. We have a record of $111 billion of cash and capital available for investment after generating $1.5 billion of net income and $1.2 billion of cash flow. We had asset sales of $21 billion and deployed $20 billion into new investments. The scale, stability and diversity of our business continues to differentiate our franchise...

YOQNEAM, Israel, Aug. 11, 2022 (GLOBE NEWSWIRE) — MIND C.T.I. LTD. – (NasdaqGM:MNDO), a leading provider of convergent end-to-end prepaid/postpaid billing and customer care product-based solutions for service providers, unified communications analytics and call accounting solutions for enterprises as well as enterprise messaging solutions, today announced results for its second quarter ended June 30, 2022. The following will summarize our major developments in the second quarter of 2022 as well as our business. The financial results can be found in the Company News section of our website at http://www.mindcti.com/company/news/ and in our Form 6-K. Financial HighlightsRevenues of $5.2 million, compared with $7.2 million in the second quarter of 2021 with the decrease mainly attributed to the messaging segment, which generated...